Anavex Life Sciences Corp (AVXL)

[Investor2014]

First those studies will need to complete enrollment.

After that the last patients in those studies will need complete dosing for 7 and 12 weeks respectively.

Then add two to three months before readout. We are looking at Q4 this year at best.

Then prepared and submit data. After that wait minimum 6 months for potential approval.

Altogether that means H2 2022.